Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:3/23/2017
Start Date:September 2009
End Date:September 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

CEPELA I Trial: Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment

This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of
a patient's esophagus before and after the RFA procedure, as the injury rate to the
esophagus has not been established.

Patients undergoing radiofrequency ablation (RFA) therapy for atrial fibrillation, can
sometimes experience insult or injury to the esophagus, due to the proximity of the
esophagus to the RFA treatment area. This study utilizes a disposable capsule endoscope
(Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA
procedure, as the injury rate to the esophagus has not been established.

Inclusion Criteria:

- Symptomatic patients with persistent atrial fibrillation selected for radiofrequency
ablation

- Adults aged 18 years and older

- Patients able to give informed consent

Exclusion Criteria:

- Patients under the age of 18

- Patient unable to or unwilling to swallow the capsule endoscopes

- Patients with cardiac pacemakers, implanted cardiac defibrillators or other implanted
electro-medical devices

- Pregnant or lactating females

- Subjects with history of abdominal, pelvic, or bowel surgery within the past year
We found this trial at
1
site
Cleveland Clinic
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials